Illumina Balance Sheet Health
Financial Health criteria checks 3/6
Illumina has a total shareholder equity of $2.1B and total debt of $2.0B, which brings its debt-to-equity ratio to 93.6%. Its total assets and total liabilities are $6.0B and $3.9B respectively. Illumina's EBIT is $338.0M making its interest coverage ratio 7.3. It has cash and short-term investments of $939.0M.
Key information
93.6%
Debt to equity ratio
US$1.99b
Debt
| Interest coverage ratio | 7.3x |
| Cash | US$939.00m |
| Equity | US$2.13b |
| Total liabilities | US$3.89b |
| Total assets | US$6.01b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ILU's short term assets ($2.4B) exceed its short term liabilities ($975.0M).
Long Term Liabilities: ILU's short term assets ($2.4B) do not cover its long term liabilities ($2.9B).
Debt to Equity History and Analysis
Debt Level: ILU's net debt to equity ratio (49.4%) is considered high.
Reducing Debt: ILU's debt to equity ratio has increased from 25.5% to 93.6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable ILU has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: ILU is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 27.6% per year.